{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T20:23:26Z","timestamp":1775939006534,"version":"3.50.1"},"reference-count":24,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Essential thrombocythemia (ET) and polycythemia vera (PV) are chronic myeloproliferative disorders that share the involvement of a multipotent progenitor cell and dominance of the transformed clone over normal hematopoiesis. On the other hand, the heterogeneity of these diseases with respect to clonal development from a common progenitor has been well established. To identify useful prognostic indicators, we analyzed telomerase activity (TA), a known marker of neoplastic proliferation, in granulocytes (PMNs) and mononuclear cells (MNCs) from 22 female patients with ET and PV. Clonality status was determined by investigation of X chromosome inactivation patterns (XCIPs). We found a statistically significant positive correlation between high TA and monoclonal pattern of XCIP. Therefore, our data suggest that the use of multiple tumor markers may contribute to a better understanding of the deregulated physiology of these disorders and provide useful prognostic factors.<\/jats:p>","DOI":"10.1182\/blood-2004-06-2375","type":"journal-article","created":{"date-parts":[[2004,10,20]],"date-time":"2004-10-20T01:18:56Z","timestamp":1098235136000},"page":"2138-2140","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["High telomerase activity in granulocytes from clonal polycythemia vera and essential thrombocythemia"],"prefix":"10.1182","volume":"105","author":[{"given":"Anna Maria","family":"Ferraris","sequence":"first","affiliation":[{"name":"From the Ematologia Oncologica, Istituto Nazionale per la Ricerca sul Cancro; the Dipartimento di Medicina Interna, University of Genova; and the Struttura Complessa di Ematologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Mangerini","sequence":"additional","affiliation":[{"name":"From the Ematologia Oncologica, Istituto Nazionale per la Ricerca sul Cancro; the Dipartimento di Medicina Interna, University of Genova; and the Struttura Complessa di Ematologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalija","family":"Pujic","sequence":"additional","affiliation":[{"name":"From the Ematologia Oncologica, Istituto Nazionale per la Ricerca sul Cancro; the Dipartimento di Medicina Interna, University of Genova; and the Struttura Complessa di Ematologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Racchi","sequence":"additional","affiliation":[{"name":"From the Ematologia Oncologica, Istituto Nazionale per la Ricerca sul Cancro; the Dipartimento di Medicina Interna, University of Genova; and the Struttura Complessa di Ematologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Rapezzi","sequence":"additional","affiliation":[{"name":"From the Ematologia Oncologica, Istituto Nazionale per la Ricerca sul Cancro; the Dipartimento di Medicina Interna, University of Genova; and the Struttura Complessa di Ematologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gallamini","sequence":"additional","affiliation":[{"name":"From the Ematologia Oncologica, Istituto Nazionale per la Ricerca sul Cancro; the Dipartimento di Medicina Interna, University of Genova; and the Struttura Complessa di Ematologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Casciaro","sequence":"additional","affiliation":[{"name":"From the Ematologia Oncologica, Istituto Nazionale per la Ricerca sul Cancro; the Dipartimento di Medicina Interna, University of Genova; and the Struttura Complessa di Ematologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Franco","family":"Gaetani","sequence":"additional","affiliation":[{"name":"From the Ematologia Oncologica, Istituto Nazionale per la Ricerca sul Cancro; the Dipartimento di Medicina Interna, University of Genova; and the Struttura Complessa di Ematologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021300005060900_REF1","doi-asserted-by":"crossref","unstructured":"Blackburn EH. Structure and function of telomere. Nature. 1991;350: 569-573.","DOI":"10.1038\/350569a0"},{"key":"2020021300005060900_REF2","doi-asserted-by":"crossref","unstructured":"Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994; 266: 2011-2015.","DOI":"10.1126\/science.7605428"},{"key":"2020021300005060900_REF3","doi-asserted-by":"crossref","unstructured":"Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A. 1995;92: 9082-9086.","DOI":"10.1073\/pnas.92.20.9082"},{"key":"2020021300005060900_REF4","doi-asserted-by":"crossref","unstructured":"Ohyashiki JH, Sashida G, Tauchi T, Ohyashiki K. Telomeres and telomerase in hematologic neoplasia. Oncogene. 2002;21: 680-687.","DOI":"10.1038\/sj.onc.1205075"},{"key":"2020021300005060900_REF5","unstructured":"Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MA. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. Cancer Res. 2000;60: 610-617."},{"key":"2020021300005060900_REF6","doi-asserted-by":"crossref","unstructured":"Terasaki Y, Okumura H, Ohtake S, Nakao S. Accelerated telomere length shortening in granulocytes: a diagnostic marker for myeloproliferative diseases. Exp Hematol. 2002;30: 1399-1404.","DOI":"10.1016\/S0301-472X(02)00969-4"},{"key":"2020021300005060900_REF7","doi-asserted-by":"crossref","unstructured":"El Kassar N, Hetet G, Li Y, Briere J, Grandchamp B. Clonal analysis of haemopoietic cells in essential thrombocythaemia. Br J Haematol. 1995;90: 131-137.","DOI":"10.1111\/j.1365-2141.1995.tb03391.x"},{"key":"2020021300005060900_","doi-asserted-by":"crossref","unstructured":"Ferraris AM, Mangerini R, Racchi O, et al. Heterogeneity of clonal development in chronic myeloproliferative disorders. Am J Hematol. 1999;60: 158-160.","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<158::AID-AJH14>3.0.CO;2-9"},{"key":"2020021300005060900_REF9","doi-asserted-by":"crossref","unstructured":"Gilliland DG, Blanchard KL, Levy J, Perrin S, Bunn HF. Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci U S A. 1991;88: 6848-6852.","DOI":"10.1073\/pnas.88.15.6848"},{"key":"2020021300005060900_REF10","unstructured":"Murphy S, Iland H, Rosenthal DS, Laszlo J. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol1986;23: 177-182."},{"key":"2020021300005060900_REF11","doi-asserted-by":"crossref","unstructured":"Racchi O, Mangerini R, Rapezzi D, Rolfo M, Gaetani GF, Ferraris AM. X chromosome inactivation patterns in normal females. Blood Cells Mol Dis. 1998;24: 439-447.","DOI":"10.1006\/bcmd.1998.0213"},{"key":"2020021300005060900_REF12","unstructured":"Ohyashiki JH, Ohyashiki K, Iwama H, Hayashi S, Toyama K, Shay JW. Clinical implications of telomerase activity levels in acute leukemia. Clin Cancer Res. 1997;3: 619-625."},{"key":"2020021300005060900_REF13","unstructured":"Gale RE, Mein CA, Linch DC. Quantification of X-chromosome inactivation patterns in haematological samples using the DNA PCR-based HUMARA assay. Leukemia. 1996;10: 362-367."},{"key":"2020021300005060900_REF14","doi-asserted-by":"crossref","unstructured":"Liu E, Jelinek J, Pastore YD, Guan Y, Prchal JF, Prchal JT. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood. 2003;101: 3294-3301.","DOI":"10.1182\/blood-2002-07-2287"},{"key":"2020021300005060900_REF15","doi-asserted-by":"crossref","unstructured":"Kralovics R, Stockton DW, Prchal JT. Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease. Blood. 2003;102: 3793-3796.","DOI":"10.1182\/blood-2003-03-0885"},{"key":"2020021300005060900_REF16","doi-asserted-by":"crossref","unstructured":"Karasawa M, Tsukamoto N, Yamane A, et al. Analysis of the distribution of CAG repeats and X-chromosome inactivation status of HUMARA gene in healthy female subjects using improved fluorescence-based assay. Int J Hematol. 2001; 74: 281-286.","DOI":"10.1007\/BF02982062"},{"key":"2020021300005060900_REF17","doi-asserted-by":"crossref","unstructured":"D'Adda T, Candidus S, Denk H, Bordi C, Hofler H. Gastric neuroendocrine neoplasms: tumour clonality and malignancy-associated large X-chromosomal deletions. J Pathol. 1999;189: 394-401.","DOI":"10.1002\/(SICI)1096-9896(199911)189:3<394::AID-PATH444>3.0.CO;2-P"},{"key":"2020021300005060900_REF18","doi-asserted-by":"crossref","unstructured":"Klippel S, Strunck E, Temerinac S, et al. Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis. Blood. 2003;102: 3569-3574.","DOI":"10.1182\/blood-2003-03-0919"},{"key":"2020021300005060900_REF19","doi-asserted-by":"crossref","unstructured":"Florensa L, Besses C, Zamora L, et al. Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential thrombocythemia. Blood. 2004;103: 2427-2428.","DOI":"10.1182\/blood-2003-10-3502"},{"key":"2020021300005060900_REF20","doi-asserted-by":"crossref","unstructured":"Streiff MB, Smith B, Spivak JL. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns. Blood. 2002;99: 1144-1149.","DOI":"10.1182\/blood.V99.4.1144"},{"key":"2020021300005060900_REF21","doi-asserted-by":"crossref","unstructured":"Shih LY, Lin TL, Lai CL, et al. Predictive values of X-chromosome inactivation patterns and clinicohematologic parameters for vascular complications in female patients with essential thrombocythemia. Blood. 2002;100: 1596-1601.","DOI":"10.1182\/blood.V100.5.1596.h81702001596_1596_1601"},{"key":"2020021300005060900_REF22","doi-asserted-by":"crossref","unstructured":"Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F. Clinical course of essential thrombocythemia in 147 cases. Cancer. 1990;66: 549-556.","DOI":"10.1002\/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6"},{"key":"2020021300005060900_REF23","doi-asserted-by":"crossref","unstructured":"Harrison CN, Gale RE, Machin SJ, Linch DC. A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. Blood. 1999;93: 417-424.","DOI":"10.1182\/blood.V93.2.417"},{"key":"2020021300005060900_REF24","doi-asserted-by":"crossref","unstructured":"Shay JW, Wright WE. Telomerase: a target for cancer therapeutics. Cancer Cell. 2002;2: 257-265.","DOI":"10.1016\/S1535-6108(02)00159-9"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/5\/2138\/1706863\/zh800505002138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/5\/2138\/1706863\/zh800505002138.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T05:01:45Z","timestamp":1581570105000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/5\/2138\/20285\/High-telomerase-activity-in-granulocytes-from"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-06-2375","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,1]]}}}